SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5065)8/4/1998 11:05:00 AM
From: Intel Trader  Read Replies (1) | Respond to of 6136
 
That guy was a joker on CNBC. Don't take too seriously. My humble op: AGPH will hold its current range. Buying opp at 25.

it



To: scaram(o)uche who wrote (5065)8/4/1998 11:07:00 AM
From: lizard lick  Respond to of 6136
 
I suppose. He is one of the regular analysts who fields questions from hosts and callers. I have emailed CNBC to get his name. He called DOW 10,000 in the next 4 months, was optimistic on most of the stocks he was asked about, but was adamant about AGPH going down.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News